Ruhollah Dorostkar

1.6k total citations
50 papers, 1.2k citations indexed

About

Ruhollah Dorostkar is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Ruhollah Dorostkar has authored 50 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Genetics and 13 papers in Infectious Diseases. Recurrent topics in Ruhollah Dorostkar's work include Virus-based gene therapy research (15 papers), RNA Interference and Gene Delivery (6 papers) and Immunotherapy and Immune Responses (6 papers). Ruhollah Dorostkar is often cited by papers focused on Virus-based gene therapy research (15 papers), RNA Interference and Gene Delivery (6 papers) and Immunotherapy and Immune Responses (6 papers). Ruhollah Dorostkar collaborates with scholars based in Iran and Hungary. Ruhollah Dorostkar's co-authors include Mahdieh Farzanehpour, Hadi Esmaeili Gouvarchin Ghaleh, Mahdi Tat, Masoumeh Bolandian, Mohammad Sadegh Hashemzadeh, Alireza Shahriary, Ali Jafarpour, Reza Ranjbar, Soleyman Heydari and Yousef Alimohamadi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomedicine & Pharmacotherapy and Frontiers in Oncology.

In The Last Decade

Ruhollah Dorostkar

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruhollah Dorostkar Iran 16 362 346 334 169 142 50 1.2k
Feihu Yan China 18 180 0.5× 400 1.2× 357 1.1× 95 0.6× 132 0.9× 75 1.0k
Lenka Zdražilová Dubská Czechia 18 288 0.8× 179 0.5× 208 0.6× 72 0.4× 130 0.9× 75 919
Thomas Günther Germany 19 569 1.6× 228 0.7× 292 0.9× 88 0.5× 133 0.9× 46 1.2k
Orna Mor Israel 24 177 0.5× 1.1k 3.1× 760 2.3× 138 0.8× 141 1.0× 103 2.3k
Natalie J. Thornburg United States 22 259 0.7× 969 2.8× 368 1.1× 60 0.4× 257 1.8× 58 1.7k
Kenneth Lai Australia 18 263 0.7× 370 1.1× 325 1.0× 55 0.3× 109 0.8× 33 1.1k
Lifang Zhang China 23 384 1.1× 258 0.7× 707 2.1× 85 0.5× 368 2.6× 113 1.7k
Anurag Sharma United States 18 208 0.6× 192 0.6× 346 1.0× 293 1.7× 98 0.7× 79 954
Kian Sing Chan Singapore 13 119 0.3× 491 1.4× 174 0.5× 28 0.2× 78 0.5× 29 990
Adam Taylor Australia 24 249 0.7× 1.1k 3.2× 424 1.3× 109 0.6× 295 2.1× 58 2.0k

Countries citing papers authored by Ruhollah Dorostkar

Since Specialization
Citations

This map shows the geographic impact of Ruhollah Dorostkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruhollah Dorostkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruhollah Dorostkar more than expected).

Fields of papers citing papers by Ruhollah Dorostkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruhollah Dorostkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruhollah Dorostkar. The network helps show where Ruhollah Dorostkar may publish in the future.

Co-authorship network of co-authors of Ruhollah Dorostkar

This figure shows the co-authorship network connecting the top 25 collaborators of Ruhollah Dorostkar. A scholar is included among the top collaborators of Ruhollah Dorostkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruhollah Dorostkar. Ruhollah Dorostkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dorostkar, Ruhollah, et al.. (2025). Antibacterial effect of a new phage, MIZ-Pa99, in the treatment of Pseudomonas aeruginosa keratitis in an animal model. Microbial Pathogenesis. 208. 107933–107933.
3.
Tat, Mahdi, et al.. (2024). The potential use of bacteriophages as antibacterial agents against Klebsiella pneumoniae. Virology Journal. 21(1). 191–191. 14 indexed citations
5.
Nazarian, Shahram, et al.. (2023). Designing and Expression of Recombinant Chimeric Spike Protein from SARS-CoV-2 in Escherichia coli and Its Immunogenicity Assessment. Iranian journal of pharmaceutical research. 22(1). e137751–e137751. 2 indexed citations
6.
Nazarian, Shahram, et al.. (2022). Recombinant expression of SARS-CoV-2 receptor binding domain (RBD) in Escherichia coli and its immunogenicity in mice.. SHILAP Revista de lepidopterología. 25(9). 1110–1116. 7 indexed citations
8.
Rezaei, Ramazan, Hadi Esmaeili Gouvarchin Ghaleh, Mahdieh Farzanehpour, et al.. (2021). Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy. Cancer Gene Therapy. 29(6). 647–660. 72 indexed citations
9.
Arpanaei, Ayyoob, et al.. (2021). Comparison of oncolytic virotherapy and nanotherapy as two new miRNA delivery approaches in lung cancer. Biomedicine & Pharmacotherapy. 140. 111755–111755. 14 indexed citations
10.
Dorostkar, Ruhollah, et al.. (2021). Chest CT-scan findings in COVID-19 patients: Relationship between the duration of symptoms and correlation with the oxygen saturation level. Romanian Journal of Military Medicine. 124(1). 29–36.
11.
Ghanizadeh, Ghader, et al.. (2020). Investigation of hospital indoor air quality for the presence of SARS-Cov-2. Journal of Environmental Health Science and Engineering. 18(2). 1259–1263. 32 indexed citations
12.
Ghaleh, Hadi Esmaeili Gouvarchin, et al.. (2020). Concise review on optimized methods in production and transduction of lentiviral vectors in order to facilitate immunotherapy and gene therapy. Biomedicine & Pharmacotherapy. 128. 110276–110276. 33 indexed citations
13.
Mostafaei, Shayan, et al.. (2017). Human endogenous retrovirus env genes: Potential blood biomarkers in lung cancer. Microbial Pathogenesis. 115. 189–193. 38 indexed citations
14.
Hashemzadeh, Mohammad Sadegh, et al.. (2017). Designing Two Individual AcMNPV Polyhedrin-Plus Bac-to-Bac Expression System in order to Express GFP and CPV-VP2 in Insect Cells. Iranian Journal of Biotechnology. 15(3). 172–178. 5 indexed citations
15.
Hashemzadeh, Mohammad Sadegh, et al.. (2016). Cloning, subcloning and recombination of VP2 gene of canine parvovirus intobaculoviral shuttle vector enabling its expression in insect cells. Der pharmacia lettre. 8(5). 119–127. 2 indexed citations
16.
Mehdizadeh, Tooraj, et al.. (2016). Chemical composition and antibacterial properties of Ocimum basilicum, Salvia officinalis and Trachyspermum ammi essential oils alone and in combination with nisin. SHILAP Revista de lepidopterología. 3(4). 51–58. 19 indexed citations
17.
Ranjbar, Saeed, et al.. (2016). Selective suppression of tumor cells by a tumor-specific bicistronic lentiviral vector. TURKISH JOURNAL OF BIOLOGY. 40. 1289–1294. 2 indexed citations
19.
Dorostkar, Ruhollah, et al.. (2016). Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer. Biomedicine & Pharmacotherapy. 84. 592–600. 47 indexed citations
20.
Hashemzadeh, Mohammad Sadegh, et al.. (2015). Cloning of fusion protein gene of Newcastle disease virus into a baculovirus derived bacmid shuttle vector, in order to express it in insect cell line. SHILAP Revista de lepidopterología. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026